A randomized, placebo-controlled clinical trial of docosahexaenoic acid supplementation for X-linked retinitis pigmentosa

American Journal of Ophthalmology

Volumn 137, Issue 4, 2004, Pages 704-718

  Hoffman, Dennis R ^a,b   Locke, Kirsten G ^a   Wheaton, Dianna H ^a   Fish, Gary E ^c   Spencer, Rand ^c   Birch, David G ^a,b  

^a RETINA FOUNDATION OF THE SOUTHWEST   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c TEXAS RETINA ASSOCIATES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOCOSAHEXAENOIC ACID; PLACEBO;

ACNE; ADOLESCENT; ADULT; ANALYSIS OF VARIANCE; ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DARK ADAPTATION; DISEASE COURSE; DRUG BLOOD LEVEL; DRUG CAPSULE; DRUG EFFECT; ELECTRORETINOGRAM; EPISTAXIS; ERUCTATION; ERYTHROCYTE; EYE FUNDUS; HUMAN; MALE; OUTCOMES RESEARCH; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RETINA CONE; RETINA ROD; RETINITIS PIGMENTOSA; SKIN BRUISING; VISUAL ACUITY; VISUAL FIELD; X CHROMOSOME LINKED DISORDER;

ADOLESCENT; ADULT; CAPSULES; CHILD; CHILD, PRESCHOOL; CONES (RETINA); DARK ADAPTATION; DIETARY SUPPLEMENTS; DOCOSAHEXAENOIC ACIDS; ELECTRORETINOGRAPHY; ERYTHROCYTE MEMBRANE; GENETIC DISEASES, X-LINKED; HUMANS; MALE; PROSPECTIVE STUDIES; RETINITIS PIGMENTOSA; VISUAL ACUITY; VISUAL FIELDS;

EID: 1842504322     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajo.2003.10.045     Document Type: Article

References (52)

1. Bunker C.H., Berson E.L., Bromley W.C., Hayes R.P., Roderick T.H. Prevalence of retinitis pigmentosa in Maine. Am J Ophthalmol. 97:1984;357-365.
2. Wheaton D.H., Daiger S.P., Birch D.G. The Southwest Eye Registry distribution of disease types and mutations. Anderson R.A., LaVail M., Hollyfield J.G. New insights into retinal degenerative diseases. 2001;339-345 Klewer-Plenum, New York.
3. Breuer D.K., Yashar B.M., Filippova F., et al. A comprehensive mutation analysis of RP2 and RPGR in a North American cohort of families with X-linked retinitis pigmentosa. Am J Hum Genet. 70:2002;1545-1554.
4. Gieser L., Fujita R., Goring H.H., et al. A novel locus (RP24) for X-linked retinitis pigmentosa maps to Xq26-27. Am J Hum Genet. 63:1998;1439-1447.
5. Fishman G.A., Farber M.D., Derlacki D.J. X-linked retinitis pigmentosa. profile of clinical findings. Arch Ophthalmol. 106:1988;369-375.
6. Birch D.G., Anderson J.L., Fish G.E. Yearly rates of rod and cone functional loss in retinitis pigmentosa and cone-rod dystrophy. Ophthalmology. 106:1999;258-268.
7. Birch D.G., Anderson J.L., Birch E.E. Early abnormalities of rod function in children with X-linked retinitis pigmentosa. Clin Vis Sci. 8:1993;329-335.
8. Bird A.C. X-linked retinitis pigmentosa. Br J Ophthalmol. 59:1975;177-199.
9. Rosenberg T., Schwahn U., Feil S., Berger W. Genotype-phenotype correlation in X-linked retinitis pigmentosa 2 (RP2). Ophthal Genet. 20:1999;161-172.
10. Sharon D., Bruns G.A.P., McGee T.L., Sandberg M.A., Berson E.L., Dryja T.P. X-linked retinitis pigmentosa mutation spectrum of the RPGR and RP2 genes and correlation with visual function. Invest Ophthalmol Vis Sci. 41:2000;2712-2721.
11. Berson E.L., Rosner B., Sandberg M.A., et al. A randomized trial of vitamin A and vitamin E supplementation for retinitis pigmentosa. Arch Ophthalmol. 111:1993;761-772.
12. Fliesler S.J., Anderson R.E. Chemistry and metabolism of lipids in the vertebrate retina. Prog Lipid Res. 22:1983;79-131.
13. Yuan C., Chen H., Anderson R.E., Kuwata O., Ebrey T.G. The unique lipid composition of gecko (Gekko Gekko) photoreceptor outer segment membranes. Comp Biochem Physiol B. 120:1998;785-789.
14. 3H-docosahexaenoyl] phosphatidate to rhodopsin during in vivo labeling of frog retinal rod outer segments. Neurochem Res. 25:2000;695-703.
15. Mitchell D.C. Why is docosahexaenoic acid essential for nervous system function? Biochem Soc Trans. 26:1998;365-370.
16. Dratz E.A., Deese A.J. The role of docosahexaenoic acid (22:6 ω-3) in biological membranes examples from photoreceptors and model membrane bilayers. Simopoulos A.P., Kifer R.R., Martin R.E. Health effects of polyunsaturated fatty acids in seafoods. 1986;319-351 Academy Press, New York.
17. Hoffman D.R. Fatty acids and visual dysfunction. Chow C.K. Fatty acids in foods and their health implications. 2000;817-842 Marcel Dekker, New York.
18. Schaefer E.J., Robins S.J., Patton G.M., et al. Red blood cell membrane phosphatidylethanolamine fatty acid content in various forms of retinitis pigmentosa. J Lipid Res. 36:1995;1427-1433.
19. Hoffman D.R., Birch D.G. Docosahexaenoic acid in red blood cells of patients with X-linked retinitis pigmentosa. Invest Ophthalmol Vis Sci. 36:1995;1009-1018.
20. Wheeler T.G., Benolken R.M., Anderson R.E. Visual membranes specificity of fatty acid precursors for the electrical response to illumination. Science. 188:1975;1312-1314.
21. Weisinger H.S., Vingrys A.J., Sinclair A.J. Effect of dietary n-3 deficiency on the electroretinogram in the guinea pig. Ann Nutr Metab. 40:1996;91-98.
22. Pawlosky R.J., Denkins Y., Ward G., Salem N.J. Retinal and brain accretion of long-chain polyunsaturated fatty acids in developing felines the effects of corn oil-based maternal diets. Am J Clin Nutr. 65:1997;465-472.
23. Neuringer M., Connor W.E., Van Patten C., Barstad L. Dietary omega-3 fatty acid deficiency and visual loss in infant rhesus monkeys. J Clin Invest. 73:1984;272-276.
24. Uauy R.D., Birch D.G., Birch E.E., Tyson J.E., Hoffman D.R. Effect of dietary omega-3 fatty acids on retinal function of very-low-birth-weight neonates. Pediatr Res. 28:1990;485-492.
25. Birch D.G., Birch E.E., Hoffman D.R., Uauy R.D. Retinal development in very-low-birth-weight infants fed diets differing in omega-3 fatty acids. Invest Ophthalmol Vis Sci. 33:1992;2365-2376.
26. Carlson S.E., Werkman S.H., Tolley E.A. Effect of long-chain n-3 fatty acid supplementation on visual acuity and growth of preterm infants with and without bronchopulmonary dysplasia. Am J Clin Nutr. 63:1996;687-697.
27. Hoffman D.R., Birch E.E., Birch D.G., et al. Impact of early dietary intake and blood lipid composition of long-chain polyunsaturated fatty acids on later visual development. J Pediatr Gastroenterol Nutr. 31:2000;540-543.
28. Hoffman D.R., Wheaton D.H., Locke K., Birch D.G. Docosahexaenoic acid (DHA) in red blood cells and electroretinographic (ERG) function in carrier heterozygotes of X-linked retinitis pigmentosa (XLRP). [Abstract] Invest Ophthalmol Vis Sci. 39:1998;S725.
29. Hoffman D.R., DeMar J.C., Heird W.C., Birch D.G., Anderson R.E. Impaired synthesis of DHA in patients with X-linked retinitis pigmentosa. J Lipid Res. 42:2001;1395-1401.
30. Wheaton D.H., Hoffman D.R., Locke K.G., Watkins R.B., Birch D.G. Biological safety assessment of docosahexaenoic acid supplementation in a randomized clinical trial for X-linked retinitis pigmentosa. Arch Ophthalmol. 121:2003;1269-1278.
31. Kyle D.J., Arterburn L.M. Single cell oil sources of docosahexaenoic acid clinical studies. Simopoulos A.P. The return of ω3 fatty acids into the food supply. 1. land-based animal food products and their health effects. World Rev Nutr Diet. 1998;116-131 Karger, Basel.
32. Jensen R.G. Lipids in human milk. Lipids. 34:2000;1243-1271.
33. Marmor M.F., Arden G.B., Nilsson S.E.G., Zrenner E. Standards for clinical electroretinography. Arch Ophthalmol. 107:1989;816-819.
34. Berson E.L., Sandberg M.A., Rosner B., Birch D.G., Hanson A.H. Natural course of retinitis pigmentosa over a three-year interval. Am J Ophthalmol. 99:1985;240-251.
35. Birch D.G., Sandberg M.A. Acquisition of submicrovolt full-field cone ERGs; artifacts and reproducibility. Doc Ophthalmol. 92:1997;269-280.
36. Birch D.G., Anderson J.L. Standardized full-field electroretinography. Normal values and their variation with age. Arch Ophthalmol. 110:1992;1571-1576.
37. Sandberg M.A., Berson E.L., Rosner B. Pigmentary retinal change and loss of electroretinogram function in retinitis pigmentosa over a three-year interval. LaVail M., Hollyfield J.G., Anderson R.E. Retinal degeneration experimental and clinical studies. 1985;109-114 Alan R. Liss, New York.
38. Sloane ME, Ball K, Owsley C, Bruni JR, Roenker DL. The visual activities questionnaire: developing an instrument for assessing problems in everyday visual tasks. In: Vision science and its applications. OSA Technical Digest Series, vol 2. Washington, DC: Optical Society of America, 1992:334-337.
39. Meindl A., Dry K., Herrmann K., et al. A gene (RPGR) with homology to the RCC1 guanine nucleotide exchange factor is mutated in X-linked retinitis pigmentosa (RP3). Nature Genet. 13:1996;35-42.
40. Vervoort R., Lennon A., Bird A., et al. Mutational hot spot within a new RPGR exon in X-linked retinitis pigmentosa. Nature Genet. 25:2000;462-466.
41. Schwahn U., Lenzner S., Dong J., et al. Positional cloning of the gene for X-linked retinitis pigmentosa 2. Nat Genet. 19:1998;327-332.
42. Grover S., Fishman G.A., Birch D.G., Locke K.G., Rosner B. Variability of full-field electroretinogram responses in subjects without diffuse photoreceptor cell disease. Ophthalmol. 110:2003;1159-1163.
43. Rosner B. Fundamentals of biostatistics. 3rd ed:1990;419-430 Duxbury Press, Boston.
44. Sandberg M.A., Weigel-DiFranco C., Rosner B., Berson E.L. The relationship between visual field size and electroretinogram amplitude in retinitis pigmentosa. Invest Ophthalmology Vis Sci. 37:1996;1693-1698.
45. Hoffman D.R., Uauy R., Birch D.G. Metabolism of omega-3 fatty acids in patients with autosomal dominant retinitis pigmentosa. Exp Eye Res. 60:1995;279-289.
46. Manrangoni F., Angeli M.T., Colli S., et al. Changes of n-3 and n-6 fatty acids in plasma and circulating cells of normal subjects, after prolonged administration of 20 5 (EPA) and 22:6 (DHA) ethyl esters and prolonged washout. Biochim Biophys Acta. 1210:1993;55-62.
47. Sarkadi-Nagy E., Wijendran V., Diau G.Y., et al. The influence of prematurity and long chain polyunsaturate supplementation in 4-week adjusted age baboon neonate brain and related tissues. Pediatr Res. 54:2003;244-252.
48. Rotstein N.P., Aveldano M.I., Barrantes F.J., Politi L.E. Docosahexaenoic acid is required for the survival of rat retinal photoreceptors in vitro. J Neurochem. 66:1996;1851-1859.
49. Kim H.-Y., Akbar M., Lau A., Edsall L. Inhibition of neuronal apoptosis by docosahexaenoic acid (22 6n-3). J Biol Chem. 275:2000;35215-35223.
50. Mizota A., Sato E., Taniai M., Adachi-Usami E., Nishikawa M. Protective effects of dietary docosahexaenoic acid against kainate-induced retinal degeneration in rats. Invest Ophthalmol Vis Sci. 42:2001;216-221.
51. Anderson R.E., Maude M., Alvarez R.A., Acland G., Aguirre G. A hypothesis to explain the reduced blood levels of docosahexaenoic acid in inherited retinal degenerations caused by mutations in genes encoding retina-specific proteins. Lipids. 34:(suppl):1999;S235-S237.
52. Buraczynska M., Wu W., Fujita R., et al. Spectrum of mutations in the RPGR gene that are identified in 20% of families with X-linked retinitis pigmentosa. Am J Hum Genet. 61:1997;1287-1292.